Compare Naturhouse Health SA with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of -10.29% and Operating profit at -23.31% over the last 5 years
- The company is Net-Debt Free
2
With ROE of 58.10%, it has a Fair valuation with a 8.65 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.32%
0%
-2.32%
6 Months
0.4%
0%
0.4%
1 Year
34.22%
0%
34.22%
2 Years
33.86%
0%
33.86%
3 Years
53.33%
0%
53.33%
4 Years
47.09%
0%
47.09%
5 Years
51.5%
0%
51.5%
Naturhouse Health SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-10.29%
EBIT Growth (5y)
-23.31%
EBIT to Interest (avg)
21.20
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
2.18
Tax Ratio
28.24%
Dividend Payout Ratio
168.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
96.42%
ROE (avg)
60.39%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
8.65
EV to EBIT
12.72
EV to EBITDA
11.37
EV to Capital Employed
29.25
EV to Sales
2.25
PEG Ratio
NA
Dividend Yield
400.39%
ROCE (Latest)
229.93%
ROE (Latest)
58.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'22 - YoY
Jun'22
Jun'21
Change(%)
Net Sales
0.00
17.50
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
6.80
-100.00%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.00
4.80
-100.00%
Operating Profit Margin (Excl OI)
0.00%
351.70%
-35.17%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2022 is -100.00% vs 50.86% in Jun 2021
Consolidated Net Profit
YoY Growth in quarter ended Jun 2022 is -100.00% vs 300.00% in Jun 2021
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
47.60
49.40
-3.64%
Operating Profit (PBDIT) excl Other Income
14.40
15.40
-6.49%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
10.10
9.90
2.02%
Operating Profit Margin (Excl OI)
279.50%
272.50%
0.70%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -3.64% vs -1.98% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.02% vs -11.61% in Dec 2024
About Naturhouse Health SA 
Naturhouse Health SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






